The selected newsroom is already in your list of favorites. Go to My Favorites

Our News on Newswise

Newswise: 67251b1c8495a_Houheadshot.jpg

Change of Ownership in Home Health Agencies May Lead to Increased Medicare Spending and Reduced Staffing Levels, According to Uthealth Houston Research

Medicare-certified home health agencies, which are key to allowing older adults to age in place, are increasingly going through ownership changes, raising concerns about health care spending, workforce, and quality of care, according to a study by...
1-Nov-2024 2:15 PM EDT Add to Favorites

Newswise: 670844b77195a_ono.jpg

$8.1M Grant Will Allow Researchers to Study the Role of Skeletal Stem Cells in Craniofacial Bone Diseases and Deformities

Researchers at UTHealth Houston have been awarded an $8.1 million grant by the National Institutes of Health (NIH) to examine skeletal stem cells as potential drivers of craniofacial bone diseases and deformities. The study is led by Noriaki Ono,...
10-Oct-2024 4:25 PM EDT Add to Favorites

Newswise: 67067be307f34_tv54570234-color-ShethandGiancardo.jpg

UTHealth Houston Awarded $2.5 Million Grant to Improve Outcomes for Stroke Patients with Large Blood Vessel Blockages

Improving clinical outcomes in stroke patients by closing a gap between successful re-opening of a blocked vessel through endovascular surgery and a reduction of disability is the focus of a $2.5 million grant awarded to UTHealth Houston researchers.
9-Oct-2024 8:05 AM EDT Add to Favorites

Newswise: 67059d73b742f_BalasubramanianBijal1.png

Improving Health Outcomes of Underserved Patients Living with Cancer Focus of $4.8m Grant to UTHealth Houston

An intervention study to improve outcomes for cancer survivors and enhance primary care capacity, funded with a $4.8 million grant from the National Cancer Institute, will be implemented by UTHealth Houston researchers in partnership with eight...
8-Oct-2024 4:05 PM EDT Add to Favorites

Newswise: 6703f55f5b0d7_11.jpg

First Infusion in Houston for New Alzheimer’s Drug Administered at UTHealth Houston

UTHealth Houston is the first institution in Houston to administer an FDA-approved drug, Kisunla (donanemab-azbt), for the treatment of early symptomatic Alzheimer’s disease.
7-Oct-2024 10:05 AM EDT Add to Favorites

Newswise: 66f439a38ed9b_DR.TANDONCLINICPHOTOSHOOT-9.jpg

UTHealth Houston’s Minimally Invasive Treatment Extends Hope to Patients with Medication-Resistant Epilepsy

Findings of a study on a novel and minimally invasive laser therapy for patients with drug-resistant epilepsy caused by periventricular nodular heterotopia (PNVH) have been published by UTHealth Houston researchers in American Neurological...
25-Sep-2024 12:05 PM EDT Add to Favorites

Newswise: 66ec5d17222ac_alzstudyphoto1.jpg

Grants for $3.5m From TARCC Fund New Alzheimer’s Disease Research at UTHealth Houston

Studies by researchers at UTHealth Houston seeking to understand the underlying pathology of Alzheimer’s disease in order to discover new pathways to treatment have earned multiple awards totaling $3.5 million from the Texas Alzheimer’s Research...
19-Sep-2024 1:05 PM EDT Add to Favorites

Newswise: 66ec7e9b9d976_Resized202407261524121722025715162.jpg

The Ocean Corporation collaborates with UTHealth Houston on Space Medicine Fellowship program

UTHealth Houston and The Ocean Corporation are collaborating on UTHealth Houston’s Space Medicine Training Fellowship program, which now includes a two-week intensive training focused on hyperbaric technologies and analog environments akin to...
19-Sep-2024 1:05 PM EDT Add to Favorites


See All News

Our YouTube Videos

About

As a comprehensive health science university, the mission of UTHealth Houston is to educate health science professionals, discover and translate advances in the biomedical and social sciences, and model the best practices in clinical care and public health.

We pursue this mission in order to advance the quality of human life by enhancing the diagnosis, treatment, and prevention of disease and injury, as well as promoting individual health and community well-being.

Experts

close
0.39333